Inflammatory carcinoma of the breast: Treatment results on 107 patients

J. N. Fields, C. A. Perez, R. R. Kuske, B. B. Fineberg, N. Bartlett

Research output: Contribution to journalArticle

59 Scopus citations

Abstract

From 1958 to 1985, 107 patients with a clinical and/or histopathologic diagnosis of non-metastatic inflammatory breast cancer received radiotherapy as all or part of initial treatment. Therapy included definitive irradiation alone in 31 patients, irradiation with mastectomy in 16 patients, irradiation and combination chemotherapy in 23 patients, and irradiation with chemotherapy and surgery in 37 patients. Survivors have a median follow-up of 30 months. Overall median relapse-free survival (RFS) was 12 months (12% at 5 years). Local control and relapse-free survival were significantly improved for patients receiving surgery as part of initial treatment: 19% (10/52) of operated patients experienced locoregional failure vs. 70% (37/53) not operated (p < 0.0001). The median overall actuarial survival was 24 months (17% at 5 years). Patients who received surgery showed improved survival (44 months vs. 18 months median; 37% vs. 7% at 5 years; p = 0.0004). Chemotherapy also was associated with improved relapse-free survival (18 months vs. 8 months median; 20% vs. 5% at 5 years; p = 0.02) and actuarial survival (32 months vs. 17 months median; 23% vs. 3% at 5 years; p < 0.02). Patients treated with initial chemotherapy (usually 2-3 cycles of CAF), surgery, and postoperative irradiation followed by maintenance chemotherapy showed a 34 month median relapse-free survival (37% at 5 years RFS) and a 47 month median survival (48% at 5 years). Moderate to severe complications were seen in 25% of patients, the most frequent complication being fibrosis of the breast or chest wall. There were two fatalities secondary to Adriamycin-induced cardiomyopathy. This study suggests better local control, with fewer complications, when surgery and irradiation are combined with multiagent chemotherapy. Further prospective clinical trials are strongly recommended.

Original languageEnglish
Pages (from-to)249-255
Number of pages7
JournalInternational journal of radiation oncology, biology, physics
Volume17
Issue number2
DOIs
StatePublished - Aug 1989

Keywords

  • Chemotherapy
  • Combined modality therapy
  • Inflammatory breast cancer
  • Radiotherapy
  • Surgery

Fingerprint Dive into the research topics of 'Inflammatory carcinoma of the breast: Treatment results on 107 patients'. Together they form a unique fingerprint.

  • Cite this